Joe Biden

In Letter To GOP Congressional Leaders, Competitiveness Coalition Sounds the Alarm on the Left's Antitrust Agenda

Retrieved on: 
Thursday, December 1, 2022
Online, McConnell, American Innovators for Patent Reform, Duck, United States Senate, White House, NBC News, Joe Biden, 117th United States Congress, Coalition, Legislation, United States House of Representatives, House, GOP, D-CT, Letter, McCarthy, Congress, Democrat, Senate, News, Competition (economics)

WASHINGTON, Dec. 1, 2022 /PRNewswire/ -- As the 117th Congress returns for the lame-duck legislative work period, the Competitiveness Coalition today issued a letter to Republican U.S. Senate Minority Leader Mitch McConnell and U.S. House Minority Leader Kevin McCarthy urging their respective caucuses to hold the line on harmful antitrust legislation, like the American Innovation and Choice Online Act (S. 2992) and the Open App Markets Act (S. 2710).

Key Points: 
  • "In light of our troubled economy, we request that you whip a 'no' vote should current Democratic leadership attempt a full Senate vote.
  • In the House, we similarly request that you resist any attempts to conflate concerns about content moderation with so-called antitrust regulations."
  • The two bills are considered the crown jewels of the antitrust agenda championed by the left's most strident antitrust advocates, including U.S.
  • The Competitiveness Coalition is a first-of-its-kind group educating the public and advocating for policies that put consumers first while fostering innovation and attracting new investment.

OCEANSIDE, CA: AHF to Shame Gilead with World AIDS Day Protest, Dec. 1

Retrieved on: 
Thursday, December 1, 2022
Infectious Diseases, Advocacy Group Opinion, Public Policy, Government, Philanthropy, AIDS, White House, Federal Government, Health, Pharmaceutical, Foundation, Trump, Gilead Sciences, EST, HHS, Pharmacy, Health, Multimedia, Hospital, Safety, Social media, Joe Biden, Patient, FAR, Hepatitis, Lawyer, PST, AHF, AIDS, AIDS Healthcare Foundation, HIV, HRSA, Pharmaceutical industry, San Francisco Bay Area

On World AIDS Day, Thursday, December 1st, advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF), will host a protest in OCEANSIDE, CA targeting drug maker Gilead Sciences over the Bay Area companys drug pricing and policies.

Key Points: 
  • On World AIDS Day, Thursday, December 1st, advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF), will host a protest in OCEANSIDE, CA targeting drug maker Gilead Sciences over the Bay Area companys drug pricing and policies.
  • This image of a mobile billboard criticizing Gilead is from an AHF protest at Gilead's headquarters in Foster City, Calif., held in October 2022.
  • On World AIDS Day, we vow to keep holding Gilead and CEO Daniel ODay accountable, whenever and wherever we can, said AHF President Michael Weinstein.
  • To learn more about AHF, please visit our website: www.aidshealth.org , find us on Facebook: www.facebook.com/aidshealth , follow us @aidshealthcare or subscribe to our AHF podcast AHFter Hours.

AHF to Shame Gilead with Nationwide Protests on World AIDS Day

Retrieved on: 
Thursday, December 1, 2022
Public Policy, Government, Pharmaceutical, AIDS, Public Policy, Health, Healthcare Reform, Infectious Diseases, Advocacy Group Opinion, Trump, Gilead Sciences, EST, HHS, Pharmacy, Health, Multimedia, Hospital, Safety, Social media, Joe Biden, Patient, FAR, Hepatitis, Lawyer, PST, AHF, AIDS, AIDS Healthcare Foundation, HIV, Reading, HRSA, Pharmaceutical industry, San Francisco Bay Area

On World AIDS Day, Thursday, December 1st, advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF), will host a series of three protests across the U.S. targeting drug maker Gilead Sciences over the Bay Area companys avarice in its drug pricing and policies.

Key Points: 
  • On World AIDS Day, Thursday, December 1st, advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF), will host a series of three protests across the U.S. targeting drug maker Gilead Sciences over the Bay Area companys avarice in its drug pricing and policies.
  • View the full release here: https://www.businesswire.com/news/home/20221129006124/en/
    AHF is spearheading 3 protests nationwide on World AIDS Day (December 1) targeting drug maker Gilead Sciences for its unbridled greed and its drug pricing and policies.
  • AHFs World AIDS Day Gilead protests follow a weeklong, twice-daily series of protests in late October targeting Gilead, maker of most of the key and most effective HIV medications and Hepatitis C drugs, at its headquarters in Foster City, CA.
  • On World AIDS Day, we vow to keep holding Gilead and CEO Daniel ODay accountable, whenever and wherever we can, said AHF President Michael Weinstein.

Northline Seafoods Announces Major Project Bringing New Innovations to the U.S. Fishing Industry

Retrieved on: 
Wednesday, November 30, 2022
Skin, Organization, Joe Biden, Northline Commons, GCL, Carbon, Short food supply chains, USDA, Port, Port of Bellingham, Freezing, Aquaculture, Whaling, Fishing, Bristol Bay

The Hannah is a one-of-a-kind vertically integrated vessel that will operate in Bristol Bay during the commercial fishing season.

Key Points: 
  • The Hannah is a one-of-a-kind vertically integrated vessel that will operate in Bristol Bay during the commercial fishing season.
  • We developed the Hannah to produce higher quality fish through a more efficient process that benefits both fishermen and customers, said Northline CEO Ben Blakey.
  • This project is a continuation of Northlines commitment to innovation and environmental sustainability in the fishing industry.
  • Northline Seafoods is a seafood processing company Headquartered in Sitka, Alaska that freezes wild salmon at the source, starting in Bristol Bay.

Monarch Private Capital Finances 363 MW of Solar Energy Installations in October

Retrieved on: 
Tuesday, November 15, 2022
Renewable energy, IRA, Solar Energy Industries Association, ESG, Private sector, Joe Biden, ITC, Solar energy, Monarch, CO2, SEIA, Investment

The addition of 363 MW of solar power to our clean energy portfolio in a single month is a landmark achievement for Monarch.

Key Points: 
  • The addition of 363 MW of solar power to our clean energy portfolio in a single month is a landmark achievement for Monarch.
  • The 363 MW of new solar energy bring Monarchs total clean power capacity to over 2 GW, abating more than 65 million MT CO2e over a 35-year lifespan.
  • Monarch Private Capital manages ESG funds that positively impact communities by creating clean power, jobs and homes.
  • Monarch Private Capital has long-term relationships with institutional and individual investors, developers and lenders that participate in these types of federal and state programs.

MMEX Resources Corp. and Trans Permian H2Hub, LLC Announce Regional H2Hub

Retrieved on: 
Monday, November 7, 2022
Permian, Hydrogen, Company, Private Securities Litigation Reform Act, CO2, Curriculum, LLC, City, Methanol, GLOBE, University of Texas Permian Basin, History, Natural gas, Asian Infrastructure Investment Bank, U.S. Department of Energy, Office of Inspector General, Rail transport by country, Wind, Siemens Energy, FOA, CEO, Harbor, Presidio, U.S. Department of Defense Strategy for Operating in Cyberspace, Safe harbor, DOE, Ammonia, Economic development, Technology, Carbon, Inflation, Funding opportunity announcement, SEC, Joe Biden, Water resources, BIL, Oil, Renewable energy, Alpine

Jack W. Hanks, President and CEO of MMEX Resources Corp., said We have filed with the DOE to start the process for the Trans Permian H2Hub.

Key Points: 
  • Jack W. Hanks, President and CEO of MMEX Resources Corp., said We have filed with the DOE to start the process for the Trans Permian H2Hub.
  • The Trans Permian H2Hub is open for participation to any interested party.
  • The new Trans Permian H2Hub website includes the MMEX Trans Permian H2Hub presentation, including several maps of the region.
  • MMEX Resources Corporation (MMEX) is a development stage company formed to engage in energy industry infrastructure projects.

NCLA Amicus Brief Supports States’ Suit Against Biden Administration's Mass Student Loan Cancellation

Retrieved on: 
Tuesday, October 25, 2022
Injury, Treasury, Public Service Loan Forgiveness, United States Court of Appeals for the Eighth Circuit, Cato, District court, COVID-19, Congress, Government, Character, Organization, Department, Education Act, PSLF, The Administrative State, Movement, HEROES, List, NCLA, GLOBE, Joe Biden, Economic policy of the Joe Biden administration, Douglas v. U.S. District Court ex rel Talk America, Motion, HEROES Act, Employment, District, Constitution, Office of Inspector General, U.S. Department of Health and Human Services, Cato Institute, Public relations, Student, Education

NCLA urges the Eighth Circuit to halt the debt cancellation plan while it considers the States arguments on appeal because the plan is so obviously unconstitutional.

Key Points: 
  • NCLA urges the Eighth Circuit to halt the debt cancellation plan while it considers the States arguments on appeal because the plan is so obviously unconstitutional.
  • It is also an appropriation because any amount of canceled debt directly reduces funds that would otherwise flow into the Treasury.
  • In short, the Department of Education relies on an unconstitutional interpretation of the HEROES Act to justify its unlawful mass debt cancellation.
  • And, like nonprofit employers, States as employers will be irreparably harmed by the Biden Administrations unlawful infringement of the PSLFs incentive structure.

AHF Advocates to Ramp Up Gilead Protests Wednesday

Retrieved on: 
Tuesday, October 25, 2022
Public Policy, Government, Pharmaceutical, AIDS, Public Policy, General Health, Health, Infectious Diseases, Advocacy Group Opinion, Congress, HRSA, AIDS Healthcare Foundation, Health, Patient, Hospital, HEP, HHS, Publication, Twitter, Instagram, Multimedia, Joe Biden, Facebook, Gilead Sciences, AIDS, HIV, Lawyer, Hepatitis C, AHF, Patent, Social media, Safety, Tenofovir alafenamide, Hepatitis, FDA, Trump, Pharmaceutical industry, Fur clothing, San Francisco Bay Area

AIDS Healthcare Foundation (AHF) will host a weeklong, twice-daily series of protests targeting drug maker of Gilead Sciences over the Bay Area companys drug pricing and policies.

Key Points: 
  • AIDS Healthcare Foundation (AHF) will host a weeklong, twice-daily series of protests targeting drug maker of Gilead Sciences over the Bay Area companys drug pricing and policies.
  • Gilead cares more about money than lives, said Jesse Brooks, AIDS advocate and AHF mobilizer.
  • In conjunction with the week of Gilead protests October 24 through October 28, AHF will also run a series of Gilead/Greediad ads in several Bay Area print and online publications.
  • Gilead is being sued by thousands of HIV patients for knowingly selling an inferior drug until its patent ran out.

AM Batteries (AMB) Secures $25M Series A Financing to Scale Manufacturing of Novel Lithium-Ion Dry-Electrode Technology

Retrieved on: 
Tuesday, October 25, 2022
Automotive, Consumer Electronics, Technology, Research, Engineering, Chemicals, Plastics, Automotive Manufacturing, Manufacturing, General Automotive, Environment, Utilities, Batteries, Green Technology, Alternative Energy, Nanotechnology, Energy, Mining, Minerals, EV, Electric Vehicles, Hardware, Science, Natural Resources, TDK, Electronics, Efficiency, Growth, AM, Science, Volkswagen, Original equipment manufacturer, AMB, Electrode, Investment, Joe Biden, Tesla, Technology, EVS, Industry, EV, Health, Board, Â, CEO, Safety, VinFast, Green Climate Fund, Solvent, Intellectual property, Robotics, Electric battery, Lithium

AM Batteries (AMB), a pioneer in lithium-ion dry-electrode technology, announced today the close of its Series A financing.

Key Points: 
  • AM Batteries (AMB), a pioneer in lithium-ion dry-electrode technology, announced today the close of its Series A financing.
  • AMBs dry-electrode manufacturing technology allows for the coating of lithium-ion battery electrodes without the need for any harmful solvents or energy-intensive evaporation.
  • When implemented at scale, AMBs technology can enable an order of magnitude reduction in both factory footprint and energy consumption for electrode manufacturing.
  • AM Batteries was founded in 2016, headquartered in Acton, MA focused on dry-electrode manufacturing for lithium-ion batteries.

‘Greediad!’ – AHF Advocates Hammer Gilead with Weeklong Protests

Retrieved on: 
Sunday, October 23, 2022
AIDS, Public Policy, Government, Health, Infectious Diseases, Advocacy Group Opinion, Pharmaceutical, Congress, HRSA, AIDS Healthcare Foundation, Health, Patient, Hospital, HEP, HHS, Publication, Twitter, Instagram, Joe Biden, Facebook, Gilead Sciences, AIDS, HIV, Lawyer, Hepatitis C, AHF, Patent, Social media, Safety, Tenofovir alafenamide, Hepatitis, FDA, Trump, Pharmaceutical industry, San Francisco Bay Area

According to a 340B Report article from March, Gilead became the 15th drug manufacturer to place unlawful restrictions on 340B contract pharmacy programs.

Key Points: 
  • According to a 340B Report article from March, Gilead became the 15th drug manufacturer to place unlawful restrictions on 340B contract pharmacy programs.
  • Moreover, according to the 340B Report, Gilead is now refusing to offer the 340B discount price for HIV drugs to providers who use contract pharmacies.
  • Gilead cares more about money than lives, said Jesse Brooks, AIDS advocate and AHF mobilizer.
  • In conjunction with the week of Gilead protests October 24 through October 28, AHF will also run a series of Gilead/Greediad ads in several Bay Area print and online publications.